We are committed to developing new medicines for patients impacted by difficult-to-treat diseases as safely and quickly as possible. We believe the best way to fulfill this commitment is through clinical studies that evaluate whether our investigational products are safe and effective, which can lead to the medicine being approved and made available to the broadest number of patients possible. Once a product is approved, we continue to evaluate our marketed products by monitoring real world data and engaging in post-marketing clinical trials.
Our clinical trials follow high medical and ethical standards, in accordance with the principles laid down in the Declaration of Helsinki, and are consistent with Good Clinical Practice and applicable local laws and regulations.?
By making clinical trial information available, we are:
- Informing patients, investigators and healthcare professionals about the clinical research we sponsor.
- Promoting the distribution of knowledge and minimizing the risk of duplication of research efforts.
- Supporting the publication of full manuscripts in peer-reviewed journals.
- Contributing towards transparency and building mutual trust.
For more information: click here